Online weight management
Online GLP-1 prescription in Rhode Island for Black patients
Telehealth services prescribing Wegovy, Zepbound, or compounded semaglutide for Black patients in Rhode Island, compared on cost, insurance acceptance, and clinical support depth. Rhode Island has expanded Medicaid; Medicaid coverage of GLP-1 for weight management remains minimal in most US states as of 2026.
Quick facts about GLP-1 access in Rhode Island
- Medicaid expansion
- Expanded
- Commercial insurance
- Coverage varies by plan; most require prior authorization for Wegovy / Zepbound
- Self-pay path
- Compounded semaglutide $199-$249/mo; branded $1,000-$1,800/mo
- Black population
- 7.5% of Rhode Island
Online GLP-1 services available in Rhode Island
All services listed below operate in Rhode Island. Editorial rankings are independent of affiliate payouts.
Hims Weight Loss
Hims Weight Loss is the most operationally reliable path to compounded semaglutide for Black women without insurance, but FDA enforcement against compounded GLP-1 may compress this option in 2026-2027.
Best for Black women who want a transparent monthly self-pay path to GLP-1 weight management and who are not eligible for branded Wegovy through insurance.
Found
Found is the most comprehensive weight-management telehealth, bundling clinician + coach + GLP-1 access at a higher monthly cost than Hims Weight Loss. Worth it if behavior change is the bottleneck, not the prescription.
Best for Black patients who want structured behavior coaching alongside GLP-1 medication, not just the prescription on its own.
Henry Meds
Henry Meds is competitive with Hims Weight Loss on price and medication menu, but operationally trails the public-company incumbents on reliability and customer-service consistency.
Best for Black patients who want flat-rate self-pay GLP-1 access and are price-shopping among compounded-semaglutide providers.
GLP-1 context in Rhode Island
Black adults have approximately 1.6x the type-2-diabetes prevalence and 57% obesity rate among Black women, the highest US rate per CDC. GLP-1 medications produce 15-20% sustained weight loss in clinical trials. Access in Rhode Island depends on insurance coverage (most plans require prior authorization for branded GLP-1) or self-pay through compounded telehealth, which is under active FDA enforcement scrutiny in 2026-2027. See our best-of GLP-1 hub for the full vendor comparison.